Page last updated: 2024-10-26

erythrosine and Cardiovascular Stroke

erythrosine has been researched along with Cardiovascular Stroke in 38 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Research Excerpts

ExcerptRelevanceReference
"Cresyl violet staining was conducted to examine neurodegeneration."1.35Enhanced cell proliferation and neuroblast differentiation in the rat hippocampal dentate gyrus following myocardial infarction. ( Choi, JH; Han, TH; Hwang, IK; Lee, CH; Lee, SY; Ryu, PD; Won, MH; Yi, SS; Yoo, KY; Yoon, YS, 2009)

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-199029 (76.32)18.7374
1990's1 (2.63)18.2507
2000's4 (10.53)29.6817
2010's2 (5.26)24.3611
2020's2 (5.26)2.80

Authors

AuthorsStudies
Radha, R1
Al-Sayah, MH1
Zhou, X1
Ding, G1
Fang, Q1
Guo, J1
Yang, L2
Wang, P1
Fu, SZ1
Li, A1
Xia, J2
Yu, J1
Ma, M1
Hu, Z1
Huang, L1
Liu, R1
Jiang, C1
Li, S1
Yu, M1
Xu, X1
Zhao, Y1
Hu, Q1
Xing, W1
Zhao, Z1
Fawzy, MS1
Ashour, H1
Shafie, AAA1
Dahman, NBH1
Fares, AM1
Antar, S1
Elnoby, AS1
Fouad, FM1
Devine, LD1
Gallagher, AM1
Briggs, S1
Hill, AJ1
Stopyra, W1
Alacamli, G1
Kaderli, ST1
Edebali, S1
Alacamli, OG1
Sul, S1
Canbek, TD1
Karalezli, A1
Stoicescu, EA1
Cherecheanu, AP1
Bostan, M1
Pîrvulescu, R1
Tiu, C1
Bujor, I1
Popa-Cherecheanu, A1
Balogun, MM1
Fashola, MB1
Shi, X1
Yu, X1
Duan, X1
Vandestienne, M1
Braik, R1
Lavillegrand, JR1
Hariri, G1
Demailly, Z1
Ben Hamouda, N1
Tamion, F1
Clavier, T1
Ait-Oufella, H1
Bampidis, V1
Azimonti, G1
Bastos, ML1
Christensen, H1
Durjava, M1
Kouba, M1
López-Alonso, M1
López Puente, S1
Marcon, F1
Mayo, B1
Pechová, A1
Petkova, M1
Ramos, F1
Sanz, Y1
Villa, RE1
Woutersen, R1
Brantom, P1
Chesson, A1
Westendorf, J1
Manini, P1
Dusemund, B1
Bickel Haase, T1
Naumann-Gola, S1
Ortner, E1
Zorn, H1
Schweiggert-Weisz, U1
Yang, N1
Gao, J1
Han, Y1
Zhang, L1
Furusawa, S1
Ikeda, M1
Ide, T1
Kanamura, T1
Miyamoto, HD1
Abe, K1
Ishimaru, K1
Watanabe, M1
Tsutsui, Y1
Miyake, R1
Fujita, S1
Tohyama, T1
Matsushima, S1
Baba, Y1
Tsutsui, H1
Dani, S1
Kumar, R1
Sharma, H1
Choudhary, RJ1
Goyal, N1
Kaur, P1
Pandit, R1
Pang, Y1
Bjornsson, R1
Chung, HR1
Miller, JE1
Suh, JD1
Margolis, G1
Hamuda, N1
Kobo, O1
Elbaz Greener, G1
Amir, O1
Homoud, M1
Madias, C1
Heist, EK1
Ruskin, JN1
Kazatsker, M1
Roguin, A1
Leshem, E1
Rozen, G1
Venugopal, J1
Rajeswari, R1
Shayanti, M1
Sridhar, R1
Sundarrajan, S1
Balamurugan, R1
Ramakrishna, S1
Meluzín, J1
Vlasín, M1
Groch, L1
Mayer, J1
Kren, L1
Rauser, P1
Tichý, B1
Hornácek, I1
Sitar, J1
Palsa, S1
Klabusay, M1
Korístek, Z1
Doubek, M1
Pospísilová, S1
Lexmaulová, L1
Dusek, L1
Hwang, IK1
Yoo, KY1
Han, TH1
Lee, CH1
Choi, JH1
Yi, SS1
Lee, SY1
Ryu, PD1
Yoon, YS1
Won, MH1
Galanzha, EI1
Sarimollaoglu, M1
Nedosekin, DA1
Keyrouz, SG1
Mehta, JL1
Zharov, VP1
SUBRAMANIAN, S1
WELLINGS, RM1
Sekine, H1
Shimizu, T1
Kosaka, S1
Kobayashi, E1
Okano, T1
Malek, P8
Ratusky, J5
Vavrejn, B4
Kronrad, L3
Kolc, J9
Schelbert, HR1
Henze, E1
Wisenberg, G1
Kasuga, N1
Polyansky, BA1
Bikbulatov, ZT1
Khryachkov, VV1
Angelos, MG1
Katz-Stein, A1
Leasure, JE1
Sato, M1
Maulik, G1
Bagchi, D1
Das, DK1
Mrhová, O2
Holman, BL2
Davis, MA2
Hanson, RN2
Gavin, JB2
Nevalainen, TJ2
Seelye, RN2
Webster, V1
Thomson, RW1
Whitehouse, S1
Donnell, M1
Kucerová, V1
Miura, T1
Downey, JM2
Ooiwa, H1
Ogawa, S1
Adachi, T1
Noto, T1
Shizukuda, Y1
Iimura, O1
Manoach, M1
Varon, D1
Neuman, M1
Netz, H1
Málek, I1
Urbanová, D1
Sandovsky, U1
Nissimov, R1
Vrána, M2
Netusil, M1
Blazek, Z2
Loisance, D1
Sadony, V1
Kaufman, H1
Sarton, MT1
Cachera, JP1
Maffei, FH1
de Franco, MF1
Hossne, WS1
Agostoni, A1
Baroldi, G1
Binaghi, PC1
Stabilini, R1
Radice, F1
Cohn, PF1
Kirk, ES1
Sonnenblick, EH1
Gorlin, R1
Myers, MB2
Cherry, G2
Ramanathan, P1
Ganatra, RD1
Daulatram, K1
Sen, PK1
Blau, M1
Veselova, EA1
Kondrat'ev, VS1
Ballaira, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
In Vivo Detection of Circulating Clots in Patients With Thromboembolism[NCT05301348]30 participants (Anticipated)Interventional2023-07-26Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for erythrosine and Cardiovascular Stroke

ArticleYear
    Emergency and critical care medicine, 2022, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm

2022
Imaging with infarct-avid agents.
    Critical reviews in diagnostic imaging, 1981, Volume: 16, Issue:3

    Topics: Animals; Chlormerodrin; Dogs; Female; Fluoresceins; Gallium Radioisotopes; Humans; Iodine Radioisoto

1981
Myocardial infarct imaging with technetium-labeled complexes.
    Seminars in nuclear medicine, 1977, Volume: 7, Issue:1

    Topics: Animals; Diphosphates; Diphosphonates; Dogs; Fluoresceins; Humans; Mercury Radioisotopes; Myocardial

1977

Trials

1 trial available for erythrosine and Cardiovascular Stroke

ArticleYear
    Emergency and critical care medicine, 2022, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm

2022

Other Studies

35 other studies available for erythrosine and Cardiovascular Stroke

ArticleYear
Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I.
    Molecules (Basel, Switzerland), 2021, Nov-19, Volume: 26, Issue:22

    Topics: Biomarkers; Early Diagnosis; Fluoresceins; Humans; Immunoassay; Liposomes; Myocardial Infarction; Tr

2021
Xylan polysaccharides fabricated into nanofibrous substrate for myocardial infarction.
    Materials science & engineering. C, Materials for biological applications, 2013, Apr-01, Volume: 33, Issue:3

    Topics: Animals; Cell Proliferation; Cell Shape; Cross-Linking Reagents; Fluoresceins; Glutaral; Immunohisto

2013
Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium. Optimization of the delivery technique.
    Cardiology, 2009, Volume: 112, Issue:2

    Topics: Animals; Bone Marrow Transplantation; Cardiac Catheterization; Catheterization; Disease Models, Anim

2009
Enhanced cell proliferation and neuroblast differentiation in the rat hippocampal dentate gyrus following myocardial infarction.
    Neuroscience letters, 2009, Feb-06, Volume: 450, Issue:3

    Topics: Animals; Benzoxazines; Biomarkers; Cell Differentiation; Cell Proliferation; Dentate Gyrus; Depressi

2009
In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts.
    Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2011, Volume: 79, Issue:10

    Topics: Animals; Blood Coagulation; Blood Platelets; Carotid Arteries; Disease Models, Animal; Early Diagnos

2011
IN VIVO AND IN VITRO STAINING OF THE MYOCARDIUM WITH FLUORESCEIN.
    The British journal of surgery, 1964, Volume: 51

    Topics: Animals; Coloring Agents; Dogs; Fluorescein; Fluoresceins; In Vitro Techniques; Myocardial Infarctio

1964
Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:3

    Topics: Animals; Animals, Newborn; Cell Communication; Disease Models, Animal; Epithelial Cells; Extracellul

2006
Ischaemia detecting radioactive substances for scanning cardiac and skeletal muscle.
    Nature, 1967, Jun-10, Volume: 214, Issue:5093

    Topics: Animals; Dogs; Fluoresceins; Iodine Radioisotopes; Ischemia; Mercury Isotopes; Muscles; Myocardial I

1967
[Experimental study on the determination of extent and size of acute myocardial ischemia (author's transl)].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1982, Volume: 30, Issue:2

    Topics: Animals; Dogs; Fluorescein; Fluoresceins; Injections, Intravenous; Intraoperative Period; Myocardial

1982
The anatomical-functional picture of the vessels in the ischaemic myocardium--a fluorescence investigation.
    Folia morphologica, 1982, Volume: 30, Issue:2

    Topics: Animals; Cats; Coronary Vessels; Dogs; Electrocardiography; Fluorescein; Fluoresceins; Humans; Myoca

1982
Early detection of myocardial infarction with magnetic resonance imaging in a canine model.
    Annals of emergency medicine, 1993, Volume: 22, Issue:9

    Topics: Animals; Blood Flow Velocity; Diagnosis, Differential; Disease Models, Animal; Dogs; Edema; Electroc

1993
Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin.
    Free radical research, 2000, Volume: 32, Issue:2

    Topics: Animals; Antioxidants; Blood Pressure; Coronary Vessels; Emodin; Fluoresceins; Free Radical Scavenge

2000
Studies on the therapeutic use of Mercurascar. Part IV: The effect of Mercurascan on some metabolic changes in experimental myocardial ischaemia. Section II: Enzymes.
    International journal of clinical pharmacology and biopharmacy, 1975, Volume: 11, Issue:1

    Topics: Acid Phosphatase; Adenosine Triphosphatases; Animals; Carboxylic Acids; Dogs; Esterases; Fluorescein

1975
An association between the onset of rigor and loss of vascular competence in early myocardial infarcts.
    Pathology, 1978, Volume: 10, Issue:3

    Topics: Animals; Autolysis; Coronary Vessels; Dogs; Elasticity; Erythrocytes; Fluoresceins; Myocardial Infar

1978
The effect of rigor mortis on the passage of erythrocytes and fluid through the myocardium of isolated dog hearts.
    Pathology, 1978, Volume: 10, Issue:3

    Topics: Animals; Coronary Vessels; Dogs; Erythrocytes; Fluoresceins; Myocardial Infarction; Myocardium; Papi

1978
Radiopharmaceuticals for acutely damaged myocardium. II: Synthesis and evaluation of [203Hg] hydroxymercurifluoresceins.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1977, Volume: 18, Issue:8

    Topics: Animals; Fluoresceins; Isotope Labeling; Male; Mercury Radioisotopes; Myocardial Infarction; Organom

1977
Studies on the therapeutic use of Mercurascar. Part III. Influence of Mercurascan on some metabolic changes in experimental myocardial ischaemia in dogs. Section I: Energetic and ionic metabolism.
    International journal of clinical pharmacology and biopharmacy, 1975, Volume: 11, Issue:1

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Creatine; Dogs; Ene

1975
Progression of myocardial infarction in a collateral flow deficient species.
    Japanese heart journal, 1989, Volume: 30, Issue:5

    Topics: Animals; Cerium Radioisotopes; Collateral Circulation; Coronary Circulation; Female; Fluoresceins; H

1989
Reduction of infarct size following acute coronary occlusion by augmenting collateral blood supply induced by infusion of tricyclic antidepressants.
    Heart and vessels, 1987, Volume: 3, Issue:2

    Topics: Animals; Antidepressive Agents, Tricyclic; Cats; Collateral Circulation; Female; Fluorescein; Fluore

1987
[Possibilities of protecting the ischemic focus in the myocardium].
    Casopis lekaru ceskych, 1985, Aug-09, Volume: 124, Issue:32

    Topics: Animals; Creatine Kinase; Dogs; Electrocardiography; Fluoresceins; Heart Rate; Myocardial Infarction

1985
[Subendocardial myocardial infarction after intravenous fluorescein].
    Harefuah, 1985, Apr-15, Volume: 108, Issue:8

    Topics: Aged; Drug Hypersensitivity; Endocardium; Female; Fluorescein; Fluoresceins; Humans; Myocardial Infa

1985
Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
    International journal of clinical pharmacology, therapy and toxicology, 1974, Volume: 10, Issue:4

    Topics: Animals; Blood Pressure; Cardiac Complexes, Premature; Coronary Vessels; Dogs; Electrodes; Fluoresce

1974
[Value of fluorescence in the macroscopic delimitation of experimental acute myocardial ischemia before and after revascularization].
    Archives des maladies du coeur et des vaisseaux, 1973, Volume: 66, Issue:6

    Topics: Animals; Cardiac Catheterization; Coronary Artery Bypass; Coronary Vessels; Dogs; Electrocardiograph

1973
Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
    International journal of clinical pharmacology, therapy and toxicology, 1974, Volume: 10, Issue:4

    Topics: Aged; Animals; Bone and Bones; Coronary Vessels; Diaphragm; Dogs; Fluoresceins; Humans; Isotope Labe

1974
[The fluorescein method in the evaluation of areas of experimental myocardial ischemia in dogs].
    AMB : revista da Associacao Medica Brasileira, 1973, Volume: 19, Issue:9

    Topics: Animals; Dogs; Evaluation Studies as Topic; Fluoresceins; Myocardial Infarction; Ultraviolet Rays

1973
Study of infarcted myocardial tissue with fluoresceinated anti-haptoglobin and anti-orosomucoid [alpha1-acid glycoprotein] sera.
    Recent advances in studies on cardiac structure and metabolism, 1972, Volume: 1

    Topics: Fluoresceins; Fluorescent Antibody Technique; Haptoglobins; Humans; Myocardial Infarction; Orosomuco

1972
Autoradiographic evaluation of myocardial collateral circulation in the canine heart.
    Cardiovascular research, 1973, Volume: 7, Issue:2

    Topics: Animals; Autoradiography; Collateral Circulation; Coronary Circulation; Dogs; Fluoresceins; Krypton;

1973
Ventricular fibrillation area thresholds in the dog and pig. Determined by a new experimental model for the production of myocardial infarction.
    The Journal of thoracic and cardiovascular surgery, 1970, Volume: 59, Issue:3

    Topics: Angiography; Animals; Cardiac Output; Coloring Agents; Disease Models, Animal; Dogs; Fluoresceins; M

1970
Effect of mercury derivatives of fluorescein on the fibrillation threshold in experimental myocardial infarction.
    Experientia, 1971, Mar-15, Volume: 27, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Fluoresceins; Mercury Isotopes; Myocardial In

1971
Uptake of 203Hg-hydroxy-mercury-fluorescein in myocardial infarcts.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1971, Volume: 12, Issue:9

    Topics: Animals; Coronary Vessels; Dogs; Fluoresceins; Kidney; Ligation; Liver; Mercury Isotopes; Myocardial

1971
Mercurascan test in ischaemia of the heart muscle caused by permanent ligature of the coronary artery.
    Review of Czechoslovak medicine, 1971, Volume: 17, Issue:1

    Topics: Animals; Coronary Vessels; Disease Models, Animal; Dogs; Fluoresceins; Mercury Isotopes; Myocardial

1971
Detection of myocardial infarction by in vivo scanning.
    Cardiologia, 1967, Volume: 51, Issue:1

    Topics: Animals; Chlormerodrin; Dogs; Fluoresceins; Injections, Intravenous; Ischemia; Mercury Isotopes; Met

1967
[The effect of strophanthin on the development of acute myocardial ischemia according to fluorescent-histochemical findings].
    Biulleten' eksperimental'noi biologii i meditsiny, 1967, Volume: 63, Issue:3

    Topics: Animals; Cats; Fluoresceins; Histocytochemistry; Ischemia; Myocardial Infarction; Myocardium; Nuclei

1967
The use of vital dyes to predict survival after experimental coronary artery ligation.
    Surgery, 1968, Volume: 63, Issue:6

    Topics: Angiocardiography; Animals; Blood Circulation; Collateral Circulation; Coronary Disease; Coronary Ve

1968
[Scintiscanning in myocardial infarct using "Mercuroscan"].
    Rivista critica di clinica medica, 1968, Volume: 68

    Topics: Cesium Isotopes; Fluoresceins; Humans; Mercury Isotopes; Myocardial Infarction; Myocardium; Radiogra

1968